Ledderhose disease

Información en español Title

Other Names:

Lederhose disease

Categories:

Rare Cancers; Skin Diseases

Summary Summary

Ledderhose disease is a type of plantar fibromatosis characterized by the growth of hard and round or flattened nodules (lumps) on the soles of the feet.^[1] It is generally seen in middle-aged and elderly people, and occurs in men about 10 times more often than in women. It typically affects both feet and progresses slowly, but not indefinitely.^[1] The nodules are often painless at first, but may cause pain when walking as they grow.^[2] People with Ledderhose disease may also have other conditions associated with the formation of excess fibrous connective tissue such as Dupuytren contracture, knuckle pads, or Peyronie disease. Repeated trauma, long-term alcohol consumption, chronic liver disease, diabetes, and epilepsy have also been reported in association with this condition. The exact cause of Ledderhose disease is not known, but heredity is thought to play a role in many cases.^[1] Treatment, if needed, may involve conservative management, steroid injections, radiotherapy, or surgery (fasciectomy and removal of the fibrous tissue). The condition has a good prognosis, although slow progression is not uncommon. Fasciectomy has been shown to reduce the rate of recurrence.^[1]^[3]

Last updated: 7/3/2018

Symptoms Symptoms

This table lists symptoms that people with this disease may have. For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed. This information comes from a database called the Human Phenotype Ontology (HPO) . The HPO collects information on symptoms that have been described in medical resources. The HPO is updated regularly. Use the HPO ID to access more in-depth information about a symptom.

Showing of 4 |

Medical Terms	Other Names	Learn More: HPO ID
80%-99% of people have these symptoms
Arthralgia	Joint pain	0002829
Lack of skin elasticity		0100679
Paresthesia	Pins and needles feeling Tingling [ more ]	0003401
30%-79% of people have these symptoms
Subcutaneous nodule	Firm lump under the skin Growth of abnormal tissue under the skin [ more ]	0001482

Showing of 4 |

Do you have more information about symptoms of this disease? We want to hear from you.

Last updated: 8/1/2020

Do you have updated information on this disease? We want to hear from you.

Treatment Treatment

Treatment options may include conservative management, radiation therapy, steroid injections and surgery. Conservative management may include using soft inserts in shoes. It may help to cut holes in the inserts or inner soles to reduce pressure on the nodules.^[4] Radiation therapy may help to stop disease progression in early stages, when nodules are very small. It may also help to shrink the size of larger nodules to relieve pain.^[4] Corticosteroid injections may be beneficial in the early stages of the disease, when there is no pain or minimal pain.^[1]^[4]^[5] If or when steroids do not help, surgery may be needed. Surgical options include fasciectomy and excision (removal) of the fibrous tissue. Fasciectomy has been shown to reduce the rate of recurrences.^[1] However, recurrence following surgery remains common.^[6]

The International Dupuytren Society provides further information on treatment options for Ledderhose disease.

Last updated: 7/3/2018

Research Research

Research helps us better understand diseases and can lead to advances in diagnosis and treatment. This section provides resources to help you learn about medical research and ways to get involved.

Clinical Research Resources

ClinicalTrials.gov lists trials that are related to Ledderhose disease. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.

Please note: Studies listed on the ClinicalTrials.gov website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.

Organizations Organizations

Support and advocacy groups can help you connect with other patients and families, and they can provide valuable services. Many develop patient-centered information and are the driving force behind research for better treatments and possible cures. They can direct you to research, resources, and services. Many organizations also have experts who serve as medical advisors or provide lists of doctors/clinics. Visit the group’s website or contact them to learn about the services they offer. Inclusion on this list is not an endorsement by GARD.

Organizations Supporting this Disease

British Dupuytren’s Society
United Kingdom
E-mail: anna@dupuytrens-society.org.uk
Website: https://dupuytrens-society.org.uk/
Dupuytren Research Group
1850 Forest Hill Blvd STE 201
West Palm Beach, FL 33406-6064
Telephone: 561-429-8279
Fax: 561-828-0494
Website: https://dupuytrens.org
International Dupuytren Society
Westerbuchberg 60b
Uebersee, 83236 Germany
E-mail: http://www.dupuytren-online.info/contactform.html
Website: http://www.dupuytren-online.info/index.html

Social Networking Websites

Visit the following Facebook groups related to Ledderhose disease:
Dupuytrens, Ledderhose and related conditions support
Ledderhose Disease or plantar fibromatosis support group

Do you know of an organization? We want to hear from you.

Learn More Learn More

These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.

In-Depth Information

Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.
PubMed is a searchable database of medical literature and lists journal articles that discuss Ledderhose disease. Click on the link to view a sample search on this topic.

News & Events News & Events

News

NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community
May 22, 2020
NCATS Translational Approach Addresses COVID-19
May 21, 2020

GARD Answers GARD Answers

Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know.

Have a question? Contact a GARD Information Specialist.

References References

Hougeir FG. Plantar Fibromatosis. Medscape Reference. May 30, 2018; http://emedicine.medscape.com/article/1061903-overview.
Ledderhose disease. International Dupuytren Society. December 28, 2016; http://www.dupuytren-online.info/morbus_ledderhose.html.
Akdag O, Yildiran G, Karamese M & Tosun Z. Dupuytren-Like Contracture of the Foot: Ledderhose Disease.. The Surgery Journaloi:10.1055/s-0036-1593355.. 2016; 2(3):102-104. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553473/.
Therapies for Ledderhose's disease (Plantar fibromatosis or Morbus Ledderhose). International Dupuytren Society. 2016; http://www.dupuytren-online.info/ledderhose_therapies.html.
Kan HJ, Hovius SE. Long-term follow-up of flaps for extensive Dupuytren's and Ledderhose disease in one family. J Plast Reconstr Aesthet Surg. 2012 Dec;65(12):1741-5; http://www.ncbi.nlm.nih.gov/pubmed/22917697.
Sheon RP, De Keyser F. Ganglia and nodules. In: Basow DS. UpToDate. Waltham, MA: UpToDate; 2013;